Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens.
about
Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data.Inherent antibacterial activity of a peptide-based beta-hairpin hydrogel.Exploring bacterial diversity in hospital environments by GS-FLX Titanium pyrosequencing.Clinical significance of the emergence of bacterial resistance in the hospital environment.Population dynamics of an Acinetobacter baumannii clonal complex during colonization of patients.Pattern of pathogens from surgical wound infections in a Nigerian hospital and their antimicrobial susceptibility profiles.Randomised trial of glutamine and selenium supplemented parenteral nutrition for critically ill patients. Protocol Version 9, 19 February 2007 known as SIGNET (Scottish Intensive care Glutamine or seleNium Evaluative Trial)Nosocomial bacterial infections in Intensive Care Units. I: Organisms and mechanisms of antibiotic resistance.Evaluation of nosocomial infections and risk factors in critically ill patientsPharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections.Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.Epidemiologically relevant antimicrobial resistance phenotypes in pathogens isolated from critically ill patients in a Brazilian Universitary HospitalDevelopment of conventional and real-time multiplex PCR assays for the detection of nosocomial pathogens.Predictors of Clostridium difficile infection severity in patients hospitalised in medical intensive care.Antimicrobial stewardship in the intensive care unit: a focus on potential pitfalls.Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital's intensive care and intermediate care units.Antimicrobial Treatment of Polymeric Medical Devices by Silver Nanomaterials and Related Technology.Investigating microbial (micro)colony heterogeneity by vibrational spectroscopy.Heart rate time series characteristics for early detection of infections in critically ill patients.Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York.The rise in bacterial resistance is partly because there have been no new classes of antibiotics since the 1960s.Incidence, risk factors, and outcome of postoperative pneumonia after microsurgical clipping of ruptured intracranial aneurysms.Subinhibitory bismuth-thiols reduce virulence of Pseudomonas aeruginosa.Using syndromic surveillance to estimate baseline rates for healthcare-associated infections in critical care units of small animal referral hospitals.Hospital-acquired pneumonia in general wards of a Japanese tertiary hospital.Intensive care unit acquired infection: a prevalence and impact on morbidity and mortality.The transmission of nosocomial pathogens in an intensive care unit: a space-time clustering and structural equation modelling approach.Resistance of Gram-Negative Bacilli in Lebanon
P2860
Q28366760-DF927FA5-B254-45D3-B658-C7BF4A542418Q31082801-8D1C0F4B-CA8C-4EC0-BF61-0935D6ED3B46Q33305110-A84C46C5-2100-4915-B0F1-3EAD996DCE94Q34406249-2724F0B9-77F8-4DCA-8EE1-A8B9DA0DDE65Q34631465-4FD61CA0-1621-498F-8C4E-D40EB8D34931Q35035712-A8AEB88C-1825-4FA8-968A-ECFABA36EAD9Q35207127-E4DBFC36-267A-4AF4-9C13-F6A0CE5698E4Q36151254-3148277E-7B43-498D-BC12-D17A4BBA9368Q36237707-9DF4D5CC-1B18-4BE7-B61D-BCE0408AECB4Q36473892-144C8498-89D4-466B-99A4-03F58D25AD88Q36777850-11D70529-4B8F-4357-B11E-BD36F596F25DQ37029217-0E9977B8-83E7-4D90-B6DB-655721D6CE53Q37159254-CE619CD4-1441-4D16-A28B-1A12F974C741Q37162298-42BAC4F0-6801-419C-A5E3-5F8A5F96B8E2Q37358642-4F79AA10-F41D-48DF-8E5B-0621D94B9BCCQ37867266-3F80A52E-769A-4703-815A-456E2A752EEAQ37993716-D209B722-EE28-4C26-9A6F-242C23CAB75AQ39140815-4120C705-E485-4F67-BB90-B11FD8B93630Q39490252-3BF5C4B9-D822-456E-BBE5-C608B95B7198Q39868452-B2DED1FC-6464-423C-B62D-5325FB51152CQ41003539-0237A755-9564-47CD-AA4C-48CECE71D276Q42765903-ADCA4D96-8B40-462E-A201-0D8C9FB7BB54Q43221296-FD3EC25E-A7CD-44CB-8E81-B24E1622657CQ44009219-F8A673B9-37FE-44DA-8D2C-4B09B853A8ECQ45870661-2869E468-09BF-4FC7-BD35-D65C29466D39Q48015631-707A3E91-46EE-41B3-8994-BD5B8CC2FA90Q51654570-A1ACD400-8858-477E-94A0-DCB426C23B0BQ51786458-176CA2AD-57AD-4379-AF1C-9BDCE1228172Q58998538-8BB7A41D-6049-45F8-A0C7-B24DA64B20E1
P2860
Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Nosocomial infections in the I ...... ntibiotic-resistant pathogens.
@ast
Nosocomial infections in the I ...... ntibiotic-resistant pathogens.
@en
Nosocomial infections in the I ...... ntibiotic-resistant pathogens.
@nl
type
label
Nosocomial infections in the I ...... ntibiotic-resistant pathogens.
@ast
Nosocomial infections in the I ...... ntibiotic-resistant pathogens.
@en
Nosocomial infections in the I ...... ntibiotic-resistant pathogens.
@nl
prefLabel
Nosocomial infections in the I ...... ntibiotic-resistant pathogens.
@ast
Nosocomial infections in the I ...... ntibiotic-resistant pathogens.
@en
Nosocomial infections in the I ...... ntibiotic-resistant pathogens.
@nl
P2093
P1433
P1476
Nosocomial infections in the I ...... ntibiotic-resistant pathogens.
@en
P2093
P304
P356
10.1378/CHEST.115.SUPPL_1.34S
P407
P433
P577
1999-03-01T00:00:00Z